Mirus Bio
Biotechnology ResearchWisconsin, United States51-200 Employees
Mirus Bio is a mid-sized biotechnology research company based in Madison, Wisconsin, with more than 25 years in operation. It develops transfection reagents and related technologies to enable nucleic acid delivery for research and development across cell and gene therapy, biopharmaceutical manufacturing, and discovery applications. The organization emphasizes technically advanced work and fosters a culture that prioritizes creativity, responsibility, and respect, aligning with its focus on delivering practical solutions for customers and partners. Its customers include product developers in the cell and gene therapy space, as well as collaborators seeking reliable delivery methods to advance their programs. In the biotechnology research industry, the company positions itself as a specialized provider of nucleic acid delivery solutions, aiming to play a meaningful role in the future of advanced therapies. In 2023, Mirus Bio collaborated with RoosterBio to develop a turn-key mRNA transfection protocol, illustrating ongoing efforts to expand practical delivery capabilities.